Adrestia Therapeutics Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Adrestia Therapeutics's estimated annual revenue is currently $8.5M per year.(i)
Adrestia Therapeutics's estimated revenue per employee is $155,000

Name	Title	Email/Phone
1 Ana Barros	Research Scientist & Laboratory Manager	Reveal Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Dermavant Scien...	$99.4M	458	40%	N/A	N/A
#2 Metrum Research...	$20.6M	133	22%	N/A	N/A
#3 Clovis Oncology	$156.1M	146	-70%	$145M	N/A
#4 ArcherDX	$3.5M	45	-25%	$150M	N/A
#5 Inscripta	$1.6M	21	0%	$459.5M	N/A
#6 Cerapedics	$67.3M	310	16%	$180.7M	N/A
#7 Stone Clinical ...	$8.5M	55	-2%	N/A	N/A
#8 Apellis Pharmac...	$256.3M	1025	9%	$168.5M	N/A
#9 CreoSalus	$2.8M	18	-33%	N/A	N/A
#10 MSBiotec	$9.1M	59	-9%	N/A	N/A

Adrestia is developing therapeutics that work in an entirely new way â€“ restoring the biological balance in damaged, diseased or dying cells.

keywords:N/A

N/A

Total Funding

Number of Employees

$8.5M

Revenue (est)

41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Spinning out of the academic research of Prof Steve Jackson at the University of Cambridge in 2018, Adrestia Therapeutics is focused on...

Adrestia Therapeutics has appointed its first full time CEO as it builds its synthetic rescue therapy platform.

CAMBRIDGE, England--(BUSINESS WIRE)-- Adrestia Therapeutics, a leader in synthetic rescue therapies for genetic diseases, today announced...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 Evelo Bioscienc...	$27M	55	-62%	$281.5M
#2 Werewolf Therap...	$7.6M	55	-7%	$128.2M
#3 Cambridge Touch	$8.4M	55	6%	N/A
#4 Closed Loop Med...	$6.9M	55	15%	N/A
#5 Gemini Therapeu...	$8.5M	55	0%	N/A